Search

everythinglearnresearchcommunity

for

Search:↓

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Minoxidil foam 5% effectively treats hair loss in both frontal and vertex scalp regions.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Genes related to pigmentation, body rhythms, and behavior change during hares' seasonal coat color transition, with a common genetic mechanism in two hare species.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Curcuma aeruginosa essential oil effectively reduces hair growth and lightens underarm skin.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Animal models are crucial for learning about hair loss and finding treatments.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

The document concludes that more research is needed to fully understand the causes of PCOS.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Young female Australian fur seals are losing hair due to low tyrosine and zinc levels and high pollution exposure.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.